← Leaderboards
Heather A Himburg
University Of California Los Angeles
$6,650,619
Attributed
$7,109,885
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,109,885 · 7
By mechanism
U01$6,304,241 · 5
P01$648,244 · 1
R21$157,400 · 1
Top collaborators
- Marjan Boerma1 shared
- Amrita Kaur Cheema1 shared
- Raphael Carl Lee1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Diana C Marquez-Garban$157,500
Others in their field
Other Emerging Leaders on “Radiation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$79,138,095
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$31,029,052
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,689,457
- Wendy Bergantz · University Of Chicago$13,233,874
Research focus
RadiationAcuteRadiation ExposureRadiation InjuriesLaboratoriesOrganInjuryAnimalsIn VivoDoseEndothelial CellsMediatingRadiation ToxicityBone MarrowRadiology SpecialtyRattusToxic EffectRecoveryExposure ToBlood VesselsGastrointestinalLungHematopoieticBase
Grant awards (15)
Mitigation of Lung / Kidney Damage$648,244
P01 · FY2025 · AI · contact PI
Advanced development of multi-omics based assays to predict late radiation organinjuries - the DEARE-Watch project$570,849
U01 · FY2025 · AI
Mitigation of multi-organ delayed effects of acute radiation exposure (DEARE) with ACE2 agonist diminazene aceturate.$546,000
U01 · FY2025 · AI · contact PI
Sex-differences in ACE2 Regulate Normal Tissue Toxicity During Gastrointestinal Acute Radiation Syndrome$535,440
U01 · FY2025 · AI · contact PI
Mitigation of GI-ARS By Stabilizing Mucosal Membrane Integrity$157,400
R21 · FY2025 · AI
Sex-differences in ACE2 Regulate Normal Tissue Toxicity During Gastrointestinal Acute Radiation Syndrome$546,000
U01 · FY2024 · AI · contact PI
Dkk1-Endothelial Progenitor Cell Treatment for the Mitigation of Hematopoietic Radiation Injury$566,250
U01 · FY2022 · AI · contact PI
Mechanism of radiation induced endovascular injury and mitigation via the Notch-Dll4 pathway$501,387
U01 · FY2022 · AI · contact PI
Mechanism of radiation induced endovascular injury and mitigation via the Notch-Dll4 pathway$100,000
U01 · FY2022 · AI · contact PI
Dkk1-Endothelial Progenitor Cell Treatment for the Mitigation of Hematopoietic Radiation Injury$780,249
U01 · FY2021 · AI · contact PI
Mechanism of radiation induced endovascular injury and mitigation via the Notch-Dll4 pathway$521,233
U01 · FY2021 · AI · contact PI
Dkk1-Endothelial Progenitor Cell Treatment for the Mitigation of Hematopoietic Radiation Injury$312,000
U01 · FY2020 · AI · contact PI
Dkk1-Endothelial Progenitor Cell Treatment for the Mitigation of Hematopoietic Radiation Injury$234,000
U01 · FY2020 · AI · contact PI
Dkk1-Endothelial Progenitor Cell Treatment for the Mitigation of Hematopoietic Radiation Injury$546,000
U01 · FY2019 · AI · contact PI
Dkk1-Endothelial Progenitor Cell Treatment for the Mitigation of Hematopoietic Radiation Injury$544,833
U01 · FY2018 · AI · contact PI